FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081110 [Registered on: 21/02/2025] Trial Registered Prospectively
Last Modified On: 23/01/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Safety and Efficacy study GURUNANDA oil pulling oral rinse in reducing sensitivity in Patients with Sensitive tooth 
Scientific Title of Study   A randomized, multi-centric, double blinded three arm, Placebo, and active Controlled parallel group comparative clinical trial to assess the efficacy and safety of Gurunanda Oil Pulling Oral Rinse in reducing the sensitivity of teeth and gums. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
GNOILRINSE/31/24 Ver 1.0 Dated 27.11.2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr R C Satish Kumar 
Designation  Principal Investigator 
Affiliation  SRM Medical College Hospital and Research Centre 
Address  Dept. of Conservative Dentistry, SRM Medical College Hospital and Research Centre

Pondicherry
PONDICHERRY
603203
India 
Phone  09843591097  
Fax    
Email  ayurbheshaja@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr M Sakthi Balan MD 
Designation  Consultant Diabetologist and CI 
Affiliation  KI3 PRIVATE LIMITED 
Address  Room No 1, No 5/3 Jayalakshmi Street,Radha Nagar, Chromepe
Chengalpattu
Chennai
TAMIL NADU
600044
India 
Phone  9443627722  
Fax    
Email  saheerose@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gayathri Sivakumar 
Designation  Director 
Affiliation  KI3 PRIVATE LIMITED 
Address  Room No 1, No 5/3 Jayalakshmi Street,Radha Nagar, Chromepet

Chennai
TAMIL NADU
600044
India 
Phone  9003109416  
Fax    
Email  drgayathri@ki3services.com  
 
Source of Monetary or Material Support  
GuruNanda LLC 6645 Caballero Blvd, Buena Park, CA 90620 
 
Primary Sponsor  
Name  GuruNanda LLC 
Address  6645 Caballero Blvd, Buena Park, CA 90620 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sihivahanan  SRM Medical College Hospital and Research Centre  Dept. of Conservative Dentistry, SRM Medical College Hospital and Research Centre
Chennai
TAMIL NADU 
99403 16750

shivahad@srmist.edu.in 
Dr Mohamed Adhil K  Vinayaka Missions Sankarachariyar Dental College  Sankari Main Road (NH-47) Ariyanoor, Salem - 636308 Tamil Nadu, India
Salem
TAMIL NADU 
7010374054

drmohamedadhil@vmsdc.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K089||Disorder of teeth and supporting structures, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Gurunanda Oil Pulling Oral Rinse  Caprylic/Capric/Lauric Triglycerides, Peppermint Oil, Spearmint Oil, Clove Oil, Cardamom oil, Tea Tree Oil, Stevia Leaf Extract, , Oregano oil, Fennel Oil, Vitamin E, Vitamin D3, Vitamin K2 Frequency:10 mL once a day. Rinse for at least 2 minutes 
Comparator Agent  Listerine Sensitivity Mouthwash  Water, Sorbitol, Propylene Glycol, Dipotassium Oxalate Monohydrate, Flavor, Phosphoric Acid, Poloxamer, Sodium Benzoate, Sodium Methyl Cocoyl Taurate, Sodium Lauryl Sulfate, Sucralose, Sodium Saccharin Use twice-daily after brushing After brushing, rinse mouth with water before use Pour 2 teaspoonfuls (10 mL) into a cup, rinse for 60 seconds, then spit out Do not exceed the recommended twice per day dose of 2 teaspoonfuls (10 mL) Do not dilute, Swallow  
Comparator Agent  Placebo Rinse  Purified Water, Glycerin, Propanediol, Xylitol, PEG Hydrogenated Castor Oil, Sodium Benzoate, Flavor, Citric Acid, Sucralose Direction of Usage: 10 mL once a day. Rinse for at least 2 minutes. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Presence of a minimum of 20 teeth
2.Presence of tooth sensitivity
3.Adequate oral hygiene and no sign of oral neglect
4.Qualifying response to the Air Blast Stimuli by Schiff Cold Air Sensitivity Scale
5.Use of a non-desensitizing dentifrice for one month prior to entry into the study
 
 
ExclusionCriteria 
Details  1.Professional teeth cleaning and whitening less than 30 days before the examination.
2.Carrying out other dental procedures, including orthodontic and surgical, less than 30 days prior to the study.
3.The use of analgesic agents less than 7 days prior to inclusion
4.Untreated dental caries or active periodontal disease .
5.Presence of cracked, chipped, or fractured teeth.
6.Severe enamel loss, dentin exposure, or pulpitis
7.Teeth whitening, scaling, or polishing within the past 4–6 weeks.
8.Recent restorations or oral surgeries that could influence sensitivity.
9.Regular use of desensitizing toothpaste or treatments within the past 4 weeks
10.Use of prescription fluoride treatments or other dental products specifically targeting sensitivity
11.Conditions affecting oral health, such as diabetes, GERD.
12.Excessive consumption of acidic foods or beverages.
13.Heavy tobacco or alcohol use that could affect oral health or study results.
14.History of bruxism, clenching, or other habits that could increase tooth wear.
15.Known allergies to any components of the products being tested.
16.Conditions or medications that might interfere with the perception of sensitivity.
17.Participation in any other clinical study or test panel within one month prior to entry into the study.
18.History of Hepatitis B or C, HIV infection.
19.Chemotherapy, radiation therapy or cytokine therapy less than 5 years before being included in the study.
20.Pregnant or lactating participants. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pharmacy-controlled Randomization 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Objective assessment of the sensitivity of hard tooth tissue, an index of the intensity of teeth hyperesthesia (IIGZ).
2.A visual analogue scale is proposed for self-assessment by the participant of the level of pain.
3.To evaluate the cleaning effect of studied products Oral Hygiene Index Simplified (OHI-S).
4.Air Blast Hypersensitivity.
5.Examiner rates the response to stimulation of hypersensitive teeth using a jet of air Response is rated based on the Schiff Cold Air Sensitivity Scale Response is rated based on the Schiff Cold Air Sensitivity Scale.
6.Reductions in extrinsic tooth stain area and extrinsic tooth stain intensity.
7.Photographic assessment of dental hygiene. 
Visit 1(Day1), Visit 2(week1), visit 3(week2), visit 4(week3), visit 5(week4) 
 
Secondary Outcome  
Outcome  TimePoints 
1.Participant and Investigator Feedback will be obtained before enrollment and after completion of the study.
2.Adverse event monitoring. 
Visit 1(Day1), Visit 2(week1), visit 3(week2), visit 4(week3), visit 5(week4) 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   28/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To assess the Efficacy and safety GURUNANDA OIL pulling oral rinse in reducing the sensitivity of teeth and gums.

Objective:1.To study the efficacy of Gurunanda Oil Pulling Oral Rinse in reducing the sensitivity of teeth and gums and                                compare with Listerine Sensitivity Mouthwash and placebo.
                 2.To assess the safety of Gurunanda Oil Pulling Oral Rinse by monitoring the occurrence of any adverse effects.

Study Design: Three-arm, parallel-group, randomized, multi-centric, double blinded, active comparator & placebo-controlled 

Primary Outcomes:
1.Objective assessment of the sensitivity of hard tooth tissue, an index of the intensity of teeth hyperesthesia (IIGZ).
2.A visual analogue scale is proposed for self-assessment by the participant of the level of pain.
3.To evaluate the cleaning effect of studied products Oral Hygiene Index Simplified (OHI-S).
4.Air Blast Hypersensitivity.
5.Examiner rates the response to stimulation of hypersensitive teeth using a jet of air  Response is rated based on the Schiff Cold Air Sensitivity Scale Response is rated based on the Schiff Cold Air Sensitivity Scale.
6.Reductions in extrinsic tooth stain area and extrinsic tooth stain intensity.
7.Photographic assessment of dental hygiene.

Secondary Outcomes:
1.Participant and Investigator Feedback will be obtained before enrollment and after completion of the study.
2.Adverse event monitoring.

Inclusion (90 participants - Each Group 45 participants)
1.Presence of a minimum of 20 teeth.
2.Presence of tooth sensitivity.
3.Adequate oral hygiene and no sign of oral neglect.
4.Qualifying response to the Air Blast Stimuli by Schiff Cold Air Sensitivity Scale.
5.Use of a non-desensitizing dentifrice for one month prior to entry into the study.

Exclusion:
1.Professional teeth cleaning and whitening less than 30 days before the examination.
2.Carrying out other dental procedures, including orthodontic and surgical, less than 30 days prior to the study.
3.The use of analgesic agents less than 7 days prior to inclusion
4.Untreated dental caries or active periodontal disease .
5.Presence of cracked, chipped, or fractured teeth.
6.Severe enamel loss, dentin exposure, or pulpitis 
7.Teeth whitening, scaling, or polishing within the past 4–6 weeks. 
8.Recent restorations or oral surgeries that could influence sensitivity. 
9.Regular use of desensitizing toothpaste or treatments within the past 4 weeks 
10.Use of prescription fluoride treatments or other dental products specifically targeting sensitivity 
11.Conditions affecting oral health, such as diabetes, GERD.
12.Excessive consumption of acidic foods or beverages.
13.Heavy tobacco or alcohol use that could affect oral health or study results. 
14.History of bruxism, clenching, or other habits that could increase tooth wear.
15.Known allergies to any components of the products being tested.
16.Conditions or medications that might interfere with the perception of sensitivity.
17.Participation in any other clinical study or test panel within one month prior to entry into the study. 
18.History of Hepatitis B or C, HIV infection.
19.Chemotherapy, radiation therapy or cytokine therapy less than 5 years before being included in the study. 
20.Pregnant or lactating participants.
 
Close